Bookmark! (press Ctrl+D)

A US biotech company has begun trials for a COVID-19 vaccine in Australia. Novavax said its vaccine works by using an adjuvant — an agent that induces a stronger immune response to a disease by boosting production of antibodies. Preliminary results from the Phase 1 clinical trial are expected in July. Phase 2 will be conducted in several countries, including the US.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here